Press Release

Dante Labs appoints Illumina acclaimed COO Bob Ragusa as Board Member to support the execution of its global integrated precision medicine strategy

July 19, 2021 07:07 ET Bob Ragusa leads Illumina global operations and is a key contributor to Illumina’s growth and global scaling.Dante Labs integrated precision medicine offering leverages the intersection of local lab operations with centralised software and database.Dante Labs mission is to accelerate science to patients to save more lives. CAMBRIDGE, United Kingdom, July …

Read full post

Dante Labs acquires Cambridge Cancer Genomics to create global excellence in precision oncology

June 23, 2021 06:07 ET ● Integrated single software platform will enable true patient-centric precision oncology at scale for cancer patients care combining medical, germline, somatic and liquid biopsy data analysis together. ● Cambridge Cancer Genomics OncOS machine learning oncology software will be integrated in Dante Labs CE-IVD, ISO13485 Immensa Genomics Interpretation Software, and it …

Read full post

Dante Labs announces appointments of Paul Jones, Simon Partridge and Christian Bourne to turbo-charge global population genomics programmes

Paul Jones, Simon Partridge and Christian Bourne, previously from Illumina and Genomics England, have joined Dante Labs in its new Cambridge, UK office to spearhead its ground-breaking global population genomics offer CAMBRIDGE, United Kingdom, May 11, 2021 — Dante Labs today announced Paul Jones, Simon Partridge and Christian Bourne have joined the Company’s Executive Team …

Read full post

Dante Labs achieves ISO 13485 certification for its Genomic Interpretation Software Immensa

Leveraging an 18 month long clinical validation study of 500,000 samples CAMBRIDGE, England–(BUSINESS WIRE)–Dante Labs, a world leader in genomic sequencing and data analysis, announced today that it received ISO 13485:2016 certification for its Immensa Genomic Interpretation Software as a medical device. The highly coveted industry certification involved a deep clinical validation study carried out …

Read full post

Dante Labs £30M investment in Cambridge will support global COVID-19 sequencing surveillance program

Dante Labs has already analysed two million and a half COVID-19 RT-PCR tests and sequenced more than 30,000 human whole genomes thanks to its Immensa™ Genome Platform CAMBRIDGE, United Kingdom, (GLOBE NEWSWIRE) – Dante Labs announced today a £30M investment in the United Kingdom to run a global surveillance programme of the new variants of …

Read full post